tandem mass spectrometry
/ TAN-dem mass spek-TROM-uh-tree /
Imagine a crowded room where you first pick out one specific person, lead them into a separate room alone, ask them to empty their pockets, and then catalog exactly what falls out. Doing two stages — first isolate, then examine the pieces — gives you far more certainty than glancing at the whole crowd. Tandem mass spectrometry works in just these two stages.
Tandem mass spectrometry, written MS/MS, uses two stages of mass analysis in sequence. The first stage selects one ion of interest (the precursor) out of everything in the sample. That chosen ion is then deliberately fragmented, and a second stage measures the masses of the resulting fragment ions. The two-step design can be done with two analyzers in space or one analyzer trapping ions over time.
It matters because isolating a precursor before fragmenting it cuts away interference and yields a clean, structure-rich spectrum, making MS/MS the gold standard for confident identification and for sensitive, selective quantitation of trace targets in messy matrices. The caveat is that you only see what you choose to select, so a poorly chosen precursor — or one that does not fragment usefully — can leave you with little information.
To measure a drug in blood, a triple quadrupole selects the drug's molecular ion in the first stage, smashes it in the middle, and watches one characteristic fragment in the third stage — a precursor-to-fragment pair so specific it ignores almost everything else in the plasma.
MS/MS isolates one ion, fragments it, then measures the pieces.
Watching a specific precursor-to-fragment transition is called selected (or multiple) reaction monitoring; it is what gives tandem mass spectrometry its remarkable selectivity for quantifying trace analytes in complex samples.